Estimaciones de analistas de Wall Street para Serina Therapeutics, Inc. (SER): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-18 | $-0.34 | ||
| 2026-08-13 | $-0.55 | $-0.47 | -17.9% |
| 2026-05-14 | $-0.58 | $-0.44 | -31.8% |
| 2026-03-23 | $-0.31 | $-0.50 | +38.0% |
| 2025-11-13 | $-0.45 | $-0.47 | +4.3% |
| 2025-08-11 | $-0.66 | $-0.36 | -83.3% |
| 2025-05-08 | $-0.49 | $-0.62 | +21.0% |
| 2025-03-24 | $-0.27 | $0.42 | -164.3% |
Ratios de valoración
| Precio / Valor contable | 2.01 |
| EV / EBITDA | -0.95 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.7M | $1.4M | $1.4M | $1.7M | $54000 | $3.5M | $500000 | $3.2M | $56000 | 0 |
| Coste de Ventas | $911000 | $685000 | $841000 | $998500 | $1.3M | $3.8M | 0 | $90000 | $194000 | 0 |
| Beneficio Bruto | $755000 | $719000 | $555000 | $729500 | -$1.2M | -$333840 | $500000 | $3.1M | -$138000 | 0 |
| I+D | $7.9M | $5.3M | $5.4M | $5.3M | $3.6M | $3.8M | $1.6M | $2.4M | $7.5M | $13.2M |
| Generales y Administrativos | $5.6M | $3.9M | $5.6M | $7.9M | $5.6M | $1.3M | $1.3M | $3.9M | $9.4M | $11.0M |
| Gastos Operativos | $13.5M | $9.1M | $11.0M | $13.3M | $9.2M | $1.3M | $2.8M | $6.2M | $16.9M | $24.0M |
| Beneficio Operativo | -$12.7M | -$8.4M | -$10.4M | -$12.6M | -$10.4M | -$1.6M | -$2.3M | -$3.1M | -$17.0M | -$24.0M |
| EBITDA | -$11.9M | -$7.7M | -$7.2M | -$11.3M | -$8.7M | -$1.2M | -$2.6M | $5.9M | -$10.5M | -$18.9M |
| Gastos por Intereses | $25000 | $12000 | 0 | 0 | $404000 | $3094 | $15878 | $558000 | $526000 | $213000 |
| Beneficio Antes de Impuestos | -$17.4M | -$6.6M | -$7.7M | -$12.2M | -$10.4M | -$1.3M | -$2.7M | $5.3M | -$11.2M | -$19.2M |
| Impuestos | 0 | 0 | 0 | $148000 | 0 | 0 | 0 | 0 | 0 | $18000 |
| Beneficio Neto | -$15.5M | -$6.6M | -$7.5M | -$12.2M | -$10.9M | -$1.3M | -$2.7M | $5.3M | -$11.1M | -$19.2M |
| BPA | $-15.21 | $-6.46 | $-7.56 | $-11.47 | $-10.14 | $-0.59 | $-2.49 | $0.63 | $-1.51 | $-1.91 |
| BPA Diluido | $-15.21 | $-6.46 | $-7.56 | $-11.47 | $-10.14 | $-0.59 | $-2.49 | $0.63 | $-1.51 | $-1.91 |
| Acciones en Circulación (Diluidas) | $1.0M | $1.0M | $992721 | $1.1M | $1.1M | $1.1M | $1.1M | $8.4M | $7.4M | $10.2M |
Precio
| Precio | $2.16 |
| Capitalización | $32M |
| Bolsa | AMEX |
| País | US |
Empresas relacionadas: ALGS · BRNS · CVM · GNTA · GRCE · INMB · JUNS
Explorar sector: Healthcare · Biotechnology
Más secciones de SER: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones